(Q37767884)

English

MELAS with recurrent complex partial seizures, nonconvulsive status epilepticus, psychosis, and behavioral disturbances: case analysis with literature review

scientific article published on 26 June 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

1 reference

Europe PubMed Central

MELAS with recurrent complex partial seizures, nonconvulsive status epilepticus, psychosis, and behavioral disturbances: case analysis with literature review (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

1 reference

based on heuristic

inferred from title

status epilepticus

1 reference

based on heuristic

inferred from title

author name string

Kenneth R Kaufman

1

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Nicole Zuber

2

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Maria A Rueda-Lara

3

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Anthony Tobia

4

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

publication date

26 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Epilepsy Behavior

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

494-497

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Prevalence, segregation, and phenotype of the mitochondrial DNA 3243A>G mutation in children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Population prevalence of the MELAS A3243G mutation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Multiple neurologic, psychiatric, and endocrine complaints in a young woman: a case discussion and review of the clinical features and management of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

An infant with a mitochondrial A3243G mutation demonstrating the MELAS phenotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

An 80-year-old mitochondrial disease patient with A3243G tRNA(Leu(UUR)) gene presenting cardiac dysfunction as the main symptom.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Cognitive decline as a manifestation of mitochondrial disorders (mitochondrial dementia).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Age and cause of death in mitochondrial diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Causes of death in pedigrees with the 3243A>G mutation in mitochondrial DNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Review of the literature on major mental disorders in adult patients with mitochondrial diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

The neuropsychologic deficits of MELAS: evidence of global impairment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Brief Communication Complex Partial Status Epilepticus in Late-Onset MELAS

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Aggressive confusional state as a clinical manifestation of status epilepticus in MELAS

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Fatal status epilepticus associated with olanzapine therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Lowered seizure threshold on olanzapine

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Olanzapine-induced myoclonic status.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

"Erratic" complex partial status epilepticus as a presenting feature of MELAS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Special report. The nature of aggression during epileptic seizures

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Recognition of the various expressions of anxiety, psychosis, and aggression in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Importance of early recognition and treatment of generalised convulsive status epilepticus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Treatment delay and the risk of prolonged status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

The clinical features, diagnosis, and prognosis of nonconvulsive status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Diagnosis and management of nonconvulsive status epilepticus in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Nonconvulsive status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

The role of mitochondria in status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

MELAS syndrome, diabetes and thyroid disease: the role of mitochondrial oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

L-carnitine and neuroprotection in the animal model of mitochondrial dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Free radical-mediated cell damage after experimental status epilepticus in hippocampal slice cultures.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Pharmacologic suppression of oxidative damage and dendritic degeneration following kainic acid-induced excitotoxicity in mouse cerebrum

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Vitamin E and L-carnitine, separately or in combination, in the prevention of radiation-induced brain and retinal damages

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Coenzyme Q 10 improves lactic acidosis, strokelike episodes, and epilepsy in a patient with MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Sodium valproate vs phenytoin in status epilepticus: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

The role of the newer antiepileptic drugs in the treatment of generalized convulsive status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Carnitine as an antidote for acute valproate toxicity in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) triggered by valproate therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Valproic acid aggravates epilepsy due to MELAS in a patient with an A3243G mutation of mitochondrial DNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Nonconvulsive status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.05.020

7 January 2021

Identifiers

10.1016/J.YEBEH.2010.05.020

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37767884&oldid=1727274040"